To further explore the molecular mechanism of PD-L1 regulating the malignant progression of lung cancer, we performed a GO enrichment analysis on the differentially expressed genes (DEGs) in two groups of patients with different PD-L1 levels obtained from the TCGA database. The gene discussed is CD274; the disease is lung carcinoma.